BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 31088992)

  • 21. Percutaneous left atrial appendage occlusion in the current practice.
    Cruz-González I; Trejo-Velasco B
    Kardiol Pol; 2021 Mar; 79(3):255-268. PubMed ID: 33687872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kidney function stratified outcomes of percutaneous left atrial appendage occlusion in patients with atrial fibrillation and high bleeding risk.
    Brockmeyer M; Wolff G; Krieger T; Lin Y; Karathanos A; Afzal S; Zeus T; Westenfeld R; Polzin A; Heinen Y; Perings S; Kelm M; Schulze V
    Acta Cardiol; 2020 Aug; 75(4):312-320. PubMed ID: 30983505
    [No Abstract]   [Full Text] [Related]  

  • 23. Stroke Risk in Patients With Atrial Fibrillation Undergoing Electrical Isolation of the Left Atrial Appendage.
    Di Biase L; Mohanty S; Trivedi C; Romero J; Natale V; Briceno D; Gadiyaram V; Couts L; Gianni C; Al-Ahmad A; Burkhardt JD; Gallinghouse GJ; Horton R; Hranitzky PM; Sanchez JE; Natale A
    J Am Coll Cardiol; 2019 Aug; 74(8):1019-1028. PubMed ID: 31439209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical follow-up of left atrial appendage occlusion in patients with atrial fibrillation ineligible of oral anticoagulation treatment-a systematic review and meta-analysis.
    Labori F; Bonander C; Persson J; Svensson M
    J Interv Card Electrophysiol; 2021 Aug; 61(2):215-225. PubMed ID: 33580847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left Atrial Appendage Occlusion: A Narrative Review.
    Alsagheir A; Koziarz A; Belley-Côté EP; Whitlock RP
    J Cardiothorac Vasc Anesth; 2019 Jun; 33(6):1753-1765. PubMed ID: 30857852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left atrial appendage occlusion with the Amplatzer Cardiac Plug could improve survival and prevent thrombo-embolic and major bleeding events in atrial fibrillation patients with increased bleeding risk.
    Budts W; Laenens D; Van Calenbergh F; Vermeersch P; De Potter T; Aminian A; Benit E; Stammen F; Kefer J
    Acta Cardiol; 2016 Apr; 71(2):135-43. PubMed ID: 27090034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-vitamin K antagonist oral anticoagulation versus left atrial appendage occlusion for primary and secondary stroke prevention after cardioembolic stroke.
    Paiva L; Coelho J; Barra S; Costa M; Sargento-Freitas J; Cunha L; Gonçalves L
    Rev Port Cardiol (Engl Ed); 2021 May; 40(5):357-365. PubMed ID: 34187638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left atrial appendage occlusion.
    Nietlispach F; Moarof I; Taramasso M; Maisano F; Meier B
    EuroIntervention; 2017 Sep; 13(AA):AA78-AA84. PubMed ID: 28942389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Twelve-month follow-up of left atrial appendage occlusion with Amplatzer Amulet.
    Kleinecke C; Park JW; Gödde M; Zintl K; Schnupp S; Brachmann J
    Cardiol J; 2017; 24(2):131-138. PubMed ID: 28198520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Left atrial appendage occlusion in patients with atrial fibrillation and large prevalence of prior intracranial bleeding.
    Barocelli F; Coli S; Crocamo A; Guidorossi A; Cattabiani MA; Preti F; Bosi D; Spaziani C; Lina D; Menozzi A; Solinas E; Pelà G; Vignali L
    J Cardiovasc Med (Hagerstown); 2020 Aug; 21(8):583-591. PubMed ID: 32443136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous left atrial appendage occlusion and risk of stroke, hospitalized bleeding and death in Medicare beneficiaries.
    Wang W; Chen LY; Walker RF; Alonso A; Norby FL; Lakshminarayan K; Lutsey PL
    Pharmacoepidemiol Drug Saf; 2024 Apr; 33(4):e5786. PubMed ID: 38565524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial experience with the WATCHMAN™ left atrial appendage system for stroke prevention in atrial fibrillation: A single-centre registry.
    Bonnet G; Salaun E; Pankert M; Cuisset T; Bonnet JL
    Arch Cardiovasc Dis; 2016 Dec; 109(12):689-695. PubMed ID: 27594651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Decision Analysis of Percutaneous Left Atrial Appendage Occlusion Relative to Novel and Traditional Oral Anticoagulation for Stroke Prevention in Patients with New-Onset Atrial Fibrillation.
    Micieli A; Wijeysundera HC; Qiu F; Atzema CL; Singh SM
    Med Decis Making; 2016 Apr; 36(3):366-74. PubMed ID: 26139448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Device-Related Thrombus After Left Atrial Appendage Occlusion With the Amulet Device.
    Peyrol M; Cautela J; Salaun E; Miola C; Franceschi F; Thuny F; Pinto J; Laine M; Maximovitch A; Paganelli F; Armero S; Bonello L
    Heart Lung Circ; 2019 Nov; 28(11):1683-1688. PubMed ID: 30301672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility of Left Atrial Appendage Occlusion in Left Atrial Appendage Thrombus: A Systematic Review.
    Sharma SP; Cheng J; Turagam MK; Gopinathannair R; Horton R; Lam YY; Tarantini G; D'Amico G; Freixa Rofastes X; Lange M; Natale A; Lakkireddy DR
    JACC Clin Electrophysiol; 2020 Apr; 6(4):414-424. PubMed ID: 32327075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual antiplatelet therapy after percutaneous left atrial appendage occlusion: single center experience with the Amplatzer Cardiac Plug.
    Bertrand PB; Habran M; Kenis K; Lecomte J; Moonen L; Stroobants D; Benit E
    Acta Cardiol; 2019 Feb; 74(1):74-81. PubMed ID: 29607737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Efficacy and Safety of Left Atrial Appendage Occlusion in Patients Aged <75 to ≥ 75 Years.
    Freixa X; Gafoor S; Regueiro A; Cruz-Gonzalez I; Shakir S; Omran H; Berti S; Santoro G; Kefer J; Landmesser U; Nielsen-Kudsk JE; Sievert H; Kanagaratnam P; Nietlispach F; Gloekler S; Aminian A; Danna P; Rezzaghi M; Stock F; Stolcova M; Costa M; Ibrahim R; Schillinger W; Park JW; Meier B; Tzikas A
    Am J Cardiol; 2016 Jan; 117(1):84-90. PubMed ID: 26552507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Patient selection for the implantation of a left atrial appendage occluder in primary and secondary prevention of cardioembolic stroke in atrial fibrillation].
    Israel CW; Ridjab D; Tschishow WN; Buddecke J
    Herzschrittmacherther Elektrophysiol; 2013 Mar; 24(1):25-32. PubMed ID: 23625310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term transesophageal echocardiography follow-up after percutaneous left atrial appendage closure.
    Staubach S; Schlatterbeck L; Mörtl M; Strohm H; Hoppmann P; Laugwitz KL; Mudra H; Ledwoch J
    Heart Rhythm; 2020 May; 17(5 Pt A):728-733. PubMed ID: 31841716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.
    Grosset-Janin D; Barth E; Bertrand B; Detante O
    Rev Neurol (Paris); 2015 May; 171(5):426-32. PubMed ID: 25912470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.